Andersen Cardiodysrhythmic Periodic Paralysis, also known as andersen syndrome, is related to thyrotoxic periodic paralysis and graves disease 1, and has symptoms including syncope An important gene associated with Andersen Cardiodysrhythmic Periodic Paralysis is KCNJ2 (Potassium Inwardly Rectifying Channel Subfamily J Member 2), and among its related pathways/superpathways are Transmission across Chemical Synapses and Cardiac conduction. The drugs Acetazolamide and Carbonic Anhydrase Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include heart and kidney, and related phenotypes are muscle weakness and periodic paralysis